Simone Pacini

Bone and bone marrow interactions: hematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide. II. Action on human hematopoietic stem cells.

Carboxy-terminal fragment of osteogenic growth peptide in vitro increases bone marrow cell density in idiopathic myelofibrosis.

Bone and bone marrow interactions: hematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide III. Action on human megakaryocytopoiesis: focus on essential thrombocythemia.

Quantitative molecular evaluation of minimal residual disease in patients with chronic lymphocytic leukemia: efficacy of in vivo purging by alemtuzumab (Campath-1H).

Carboxy-terminal fragment of osteogenic growth peptide regulates myeloid differentiation through RhoA.

Quantitative molecular monitoring of BCR-ABL and MDR1 transcripts in patients with chronic myeloid leukemia during Imatinib treatment.

Primary lymphoma of the bladder: case report.

Chimerism does not influence graft-versus-myeloma and graft-versus-host disease in reduced intensity setting.

RAF-1 over-expression does condition survival of patients affected by aggressive mantle cell lymphoma.

Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen.

Human autologous plasma-derived clot as a biological scaffold for mesenchymal stem cells in treatment of orthopedic healing.

Suspension of bone marrow-derived undifferentiated mesenchymal stromal cells for repair of superficial digital flexor tendon in race horses.

Gelatin/PLLA sponge-like scaffolds allow proliferation and osteogenic differentiation of human mesenchymal stromal cells.

Good manufacturing practice-grade fibrin gel is useful as a scaffold for human mesenchymal stromal cells and supports in vitro osteogenic differentiation.

Identification and purification of mesodermal progenitor cells from human adult bone marrow.

Selective culture of mesodermal progenitor cells.

Constitutive expression of pluripotency-associated genes in mesodermal progenitor cells (MPCs).

Mesodermal progenitor cells (MPCs) differentiate into mesenchymal stromal cells (MSCs) by activation of Wnt5/calmodulin signalling pathway.

Impaired function of gamma-delta lymphocytes in melanoma patients.

Endothelial differentiation of mesenchymal stromal cells: when traditional biology meets mechanotransduction.

Specific integrin expression is associated with podosome-like structures on mesodermal progenitor cells.

Plasticity of human dental pulp stromal cells with bioengineering platforms: a versatile tool for regenerative medicine.

Are MSCs angiogenic cells? New insights on human nestin-positive bone marrow-derived multipotent cells.

Deterministic and stochastic approaches in the clinical application of mesenchymal stromal cells (MSCs).

Combination of CD157 and FLAER to Detect Peripheral Blood Eosinophils by Multiparameter Flow Cytometry.

Mesangiogenic Progenitor Cells Derived from One Novel CD64(bright)CD31(bright)CD14(neg) Population in Human Adult Bone Marrow.